News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Will the FDA Yank Bayer HealthCare Pharmaceuticals (BAYA.F)'s Risky Birth-Control Pill Yaz?; FDA Continues to Monitor Clot Risk Six Months Later


9/27/2011 6:55:47 AM

NEW YORK--(BUSINESS WIRE)-- The U.S. Food and Drug Administration issued a statement today that the FDA remains concerned, but has not yet reached a conclusion, about the potential increased risk of blood clots from Drospirenone-containing birth control pills such as YAZ, YASMIN, BEYAZ, and OCELLA, among others.

Preliminary results from an FDA-sponsored study of 800,000 women taking birth control pills shows that there is a 1.5 increased risk among Drospirenone-containing pill users.

To address these concerns, the FDA has scheduled an important meeting for December 8, 2011. The FDA will hear testimony concerning these studies and the safety of these medications. The meeting is open to the public.

Commenting on the FDA warning, Wendy Fleishman, a prominent personal injury attorney with the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, stated, “Too many active and healthy women have suddenly died from, or suffered severe, life-threatening blood clots allegedly caused by taking Drospirenone-containing birth control pills, like YAZ. We are wholly supportive of birth control choices for young women, but women need to be accurately informed of the potential risks when they take a birth control pill. We hope that the FDA's review will cause Bayer to take the responsible course of action and fully disclose the dangers this drug poses.”

YAZ Birth Control Injury Law - Legal Resources for Patients

If you or a family member have suffered a serious injury or a loved one died after being prescribed YAZ or YASMIN, please visit http://www.yazbirthcontrolinjurylaw.com/ to learn more about your legal rights, watch a short video on the risks posed by YAZ and YASMIN, and submit your complaint.

Experienced personal injury attorneys at Lieff Cabraser will promptly review each case submitted without charge or obligation.

Trademark Notice

Yaz and Yasmin are registered trademarks of Bayer Schering Pharma Aktiengesellschaft and used for informational and product identification purposes only.

About Lieff Cabraser

Lieff Cabraser Heimann & Bernstein, LLP, is a sixty-plus attorney law firm founded in 1972 with offices in San Francisco, New York and Nashville. Described by The American Lawyer as “one of the nation’s premier plaintiffs’ firms,” Lieff Cabraser enjoys a national reputation for professional integrity and the successful prosecution of our clients’ claims.

In the 2010 edition of its annual list of the top plaintiffs’ law firms, The National Law Journal again selected Lieff Cabraser. Lieff Cabraser is one of only two plaintiffs’ law firms in the United States to receive this honor for the last eight years.

Learn more about our firm at www.lieffcabraser.com.

Contact:

Lieff Cabraser Heimann & Bernstein, LLPWendy R. Fleishman, 212-355-9500


Read at BioSpace.com
Read at Fox News
Read at Wall Street Journal
Read at US News
Read at BNET


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES